Intelligene智新生技
@intelli-gene.com
We are Intelligene. We aim to redefine the boundaries of medicine and to improve global health by harnessing the revolutionary power of our RNA technology platform. Intelligene stands as one of the pioneering drug development companies in Taiwan's biotechnology sector. We are at the forefront of advancing gene therapeutics through RNA-based drugs, utilizing a revolutionary approach that harnesses the power of RNA interference technology to combat formidable adversaries. Our mission is to use quickly adaptable biologics to neutralize present and future threats of influenza, pandemics, and other communicable diseases. Our dedicated team of scientists and researchers is united by a shared purpose: to safeguard and improve human well-being by developing innovative solutions. These solutions not only address the immediate challenges posed by infectious diseases but also hold the promise of a healthier future.
Intelligene智新生技's Company Logos
Intelligene智新生技's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#1D19A0
Jacksons Purple
29, 25, 160
242, 73, 36
82, 84, 0, 37
#8DE7E5
Riptide
141, 231, 229
179, 65, 73
39, 0, 1, 9
#01243A
Daintree
1, 36, 58
203, 97, 12
98, 38, 0, 77
About Intelligene智新生技
Intelligene is a pioneering biotech company in Taiwan, established on June 2, 2023. Specializing in innovative RNA gene therapy drugs, Intelligene aims to lead the development of genetic medical treatments in Taiwan. The research and development team at Intelligene is focused on tackling immediate challenges posed by infectious diseases.
Leveraging RNA interference technology, they decode and develop nucleic acid drugs to protect human health, aiming for precise treatments. By advancing gene therapy, Intelligene is committed to improving public health and addressing the challenges posed by viral infections. Led by a team of experienced professionals, including top executives and scientific advisors, Intelligene is dedicated to scientific innovation to create a healthier future.
For more information on their core technology, new drug products, and media releases, visit their website. Join Intelligene in shaping the future of healthcare
Company type
Privately Held
Year founded
2023
Company size
11-50 employees
